NCT03680885 - Validating a New Non-invasive Approach to Testing Lidocaine Effectiveness | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 1, 2019

Primary Completion Date

March 30, 2020

Study Completion Date

March 30, 2020

Conditions

ADHDControls

Interventions

DRUG

Lidocaine gel

Lidocaine gel 5%, PEG with FD\&C Blue No.1 (Brilliant Blue FCF)

DRUG

Placebo

PEG with FD\&C Blue No.1 (Brilliant Blue FCF)

DRUG

Injected lidocaine

Standard FDA-approved dental injectable lidocaine

Trial Locations (1)

Jacobi Medical Center, The Bronx